Photo of Mone Zaidi

Mone Zaidi

  • PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
  • PROFESSOR Structural and Chemical Biology
  • PROFESSOR Geriatrics and Palliative Medicine
Print ProfilePrint Profile

Education

  • PHD, Royal Postgraduate Medical School

  • MBBS, King George's Medical College

  • MD, University of London

  • Residency, Medicine-Endoc
    Royal Postgraduate Medical School

Awards

  • -
    Award
    Sir Edmund Davis Scholarship

  • -
    Elected
    Department of Veterans Affairs Endocrine Merit Review Committee

  • -
    Research Excellence Award - Department of Veterans Affairs
    NIH Orthopedics and Musculoskeletal Study Section

  • -
    Fellow
    Royal College of Physicians

  • -
    Member
    Association of Osteobiology, Interurban Clinical Club, Councilor

  • 2010 -
    Sreebny Distinguished Lecture,
    State University of New York, Stony Brook,

  • 2010 -
    Honorary Doctor of Medicine (Laurea Honoris Causa),
    University of Bari

  • 2009 -
    The Marookian Lecture
    University of Pennsylvania

  • 2008 -
    Kramer Visiting Professor
    Dartmouth Medical School

  • 2008 -
    Sibte H. Zaidi Memorial Oration
    Indian Institute of Toxicology Research, India

  • 2006 -
    Hightlight Speaker
    NIA Council

  • 2005 - 2006
    Scientific Director and Chair
    New York Skeletal Biology and Medicine Conferences Highlight Speaker, NIA Council

  • 2005 - 2006
    Invited Speaker
    Japanese Bone and Mineral society

  • 2004 -
    Elected
    Association of American Physicians

  • 2002 -
    Eweson Lecturer
    Cambridge Philosophical Society

  • 2001 -
    National Scientific Advisory Council & Research Committee
    American Federation for Aging Research

  • 2000 -
    Foster Lecture
    University of Cambridge

  • 2000 -
    Elected
    Department of Veterans Affairs Merit Review Council

  • 2000 - 2003
    Elected
    Department of Veterans Affairs Medical Research Advisory Group

  • 2000 -
    Member
    American Society for Clinical Investigation

  • 1998 -
    Fellow
    Royal College of Pathologists

  • 1995 -
    Fellow
    Institute of Biologists of England

  • 1995 -
    Award
    Tata Memorial Scholar, London

  • 1988 -
    Lecturer
    Nuffield Award for Science Lecturer, London

  • 1983 -
    Award
    Stott Gold Medal in Pathology

Research

Research

Mone Zaidi has made seminal contributions to the pathogenesis and therapy of osteoporosis, a devastating public health hazard.  These include the first description of extracellular calcium sensing by the osteoclast; evidence that nuclear calcium in bone cells is tightly regulated by ryanodine receptors; and the discovery that nitric oxide controls osteoclast function.  More recently, he established the concept of a pituitary-bone axis, in which the pituitary hormones FSH, TSH, ACTH and oxytocin directly regulate the skeleton.  The idea that low TSH contributes to the osteoporosis of thyroid disorders has led to revised criteria that mandate less aggressive TSH suppression.  Similarly, the rapid late peri-menopausal bone loss, which is now partly attributable to a rising FSH, has prompted new guidelines for early evaluation of women.  The finding that ACTH attenuates avascular necrosis of the hip will likewise help prevent this crippling complication of long-term steroid use.  Finally, Dr. Zaidi has proven that the inhibition of calcineurin in the osteoblast by the widely used immunosuppressant drugs cyclosporine and tacrolimus underlies the acute, rapid, and severe bone loss in transplant patients.  These observations have thus created new paradigms for understanding and treating osteoporosis.  Importantly, Dr. Zaidi has chaired several standing study sections, and has conceptualized and runs one of the most revered international conferences in skeletal biology and medicine.

Publications

Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, Zhu LL, Liu X, Liu JH, Peng YZ, Yang G, Sun H, Levine A, Iqbal J, Yaroslavskiy BB, Isales C, Blair HC, . ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proceedings of the National Academy of Science 2010;(107): 8782-8787.

Iqbal J, Sun L, Zaidi M. Coupling bone degradation and formation.. Nature Medicine 2009;(15): 729-731.

Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano MM, Faccio R, Liu X, Li J, Usmani S, Nishimori K, Young L, Bachar M, Bab I, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone.. Proceeding of the national Academy of Science 2008;(106): 7149-7154.

Sun L, Vukicevic S, Baliram A, Yang G, Sendak R, McPherson J, Zhu LL, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah KO, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K, Zaidi M, , . Intermittent recombinant TSH injection prevents ovariectomy-induced bone loss.. Proceedings of the national Academy of Sciences 2008;(105): 4289-4294.

Zaidi M. Skeletal remodeling in health and disease. Nature Medicine 2007;(13): 791-801.

Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M. FSH stimulates TNF production from immune cells to trigger osteoclast and osteoblast formation.. Proceedings of the National Academy of Sciences;(103): 14925-14930.

Hase H, Ando T, Eldeiry L, Brebene A, Peng Y, Lin L, Amano H, Davies TF, Sun L, Zaidi M, Abe E. TNF mediates the skeletal effects of TSH. Proceedings of the National Academy of Sciences;(103): 12849-12854.

Sun L, Zhang Z, Iqbal J, Zaidi S, Papachristou DJ, Zhou H, Sharrow AC, Peng Y, Yaroslavskiy BB, Zhu LL, Zallone A, Sairam MR, Kumar TR, Landa LC, Schaffler MB, Moonga BS, Blair HC, Zaidi M. FSH directly regulates bone mass.. Cell 2006;(125): 247-260.

Sun L, Blair HC, Peng Y, Zaidi N, Adebanjo OA, Wu XB, Wu XY, Iqbal J, Epstein S, Abe E, Moonga BS, Zaidi M. Calcineurin regulates bone formation by the osteoblast.. Proceedings of the National Academy of Sciences 2005;(47): 17130-17135.

Abe E, Marians R, Wu XB, Iqbal J, Ando T, Blair HC, Davies TF, Zaidi M. TSH is a negative regulator of bone remodelling.. Cell;(175): 151-162.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Zaidi during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Gerson Lehrman Group; GlaxoSmithKline; Merck & Co., Inc.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Amgen Inc.; Nycomed ( Takeda Pharmaceuticals International GmbH); Teijin Limited

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Atran Berg Laboratory Building Floor 4th floor Room AB4-06
1428 Madison Avenue
New York, NY 10029

Tel: 212-241-8797
Fax: 212-426-8312
Endocrinology, Diabetes and Bone Disease

5 East 98th Street
11th Floor
New York, NY 10029

Tel: 212-241-7975
Fax: 212-423-0508
Get Directions
Insurance Plans
  • 1199 Member Choice
  • Aetna POS
  • Aetna PPO
  • Aetna U.S. Healthcare - HMO
  • Devon Health Services
  • HealthNet
  • Medicaid
  • Medicare
  • Oxford Freedom
  • Oxford Liberty
  • Touchstone
  • United Health Care - Mount Sinai Top Tier
  • United Health Care Commercial
  • United Health Care Empire Plan